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The purpose of this study was to evaluate the clinical efficiency of desmopressine and diclofenac in in-
continent patients with nocturnal polyuria and polyuria. A total of 277 patients ≥18 ≤ 55 years of age 
with complaints of urinary incontinence were included. 143 women had stress incontinence, 43 — urge 
incontinence and 91 — mixed incontinence. The overall prevalence of nocturia was 34.7 ± 2.9% (96 wo- 
men). The frequency of poliuriya was 7 ± 2.1 % in stress incontinence, 11.6 ± 4.9 % in urge incon-
tinence and 9.9 ± 3.1 % in mixed incontinence (p > 0.05). The frequency of nocturnal polyuria was 
17.5 ± 3.2% in stress incontinence, 27.9 ± 6.8% in urge incontinence and 25.3 ± 4.6 % mixed incon-
tinence (p > 0.05). Patients were randomized to receive either desmopressin or diclofenac in a dou-
ble — blind fashion. The statistically significant recovery of renal function occurred in 8 incontinent 
women with polyuria and 19 with nocturnal polyuria who received diclofenac and in 12 incontinent 
women with polyuria and 18 with nocturnal polyuria who received desmopressin (Minirin). Refs 5. 
Figs 12. Table 1.
Keywords: renal osmoregulatoin function, incontinence, sodium excretion, desmopressin, diclo- 
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КОРРЕКЦИЯ ФУНКЦИИ ПОЧКИ ДЕСМОПРЕССИНОМ И ДИКЛОФЕНАКОМ 
У ЖЕНЩИН С НЕДЕРЖАНИЕМ МОЧИ И НОКТУРИЕЙ
Н. А. Осипова, Д. А. Ниаури, А. М. Гзгзян, Л. Х. Джемлиханова
Санкт-Петербургский государственный университет, 
Российская Федерация, 199034, Санкт-Петербург, Университетская наб., 7–9
Настоящее исследование было проведено с  целью оценки клинической эффективности 
десмопрессина и  диклофенака при недержании мочи у  женщин с  ноктурией и  полиурией. 
В  исследование были включены 277  пациенток в  возрасте ≥ 18 ≤ 55  лет с  жалобами на не-
держание мочи. У 143 женщин было выявлено стрессовое недержание мочи, 43 — импера-
тивное и у 91 — смешанное. Частота развития ноктурии составила 34.7 ± 2.9% (96 женщин): 
24.5 ± 3.6 % (35 женщин) со стрессовым недержанием мочи, 46.5 ± 7.6 % (20 женщин) с импера-
тивным (p < 0.01) и 45.1 ± 5.2% (41женщина) со смешанным (p < 0.01). Частота развития поли-
урии составила 7 ± 2.1 % при стрессовом недержании мочи, 11.6 ± 4.9 % — при императивном 
и 9.9 ± 3.1 % при смешанном (p > 0.05). Частота развития ноктурии составила 17.5 ± 3.2 % при 
стрессовом недержании мочи, 27.9 ± 6.8 % при императивном и  25.3 ± 4.6 % при смешанном 
недержании (p > 0.05). Нормализация функции почки произошла у 8 пациенток с полиурией 
и 19 — ноктурией, которые получали диклофенак и у 12 пациенток с полиурией и 18 с нокт- 
урией, которые получали десмопрессин (Minirin). У этих пациенток было выявлено достовер-
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ное снижение диуреза, экскреции осмотически активных веществ, а именно ионов натрия, 
калия, магния. Библиогр. 5 назв. Ил. 12. Табл. 1.
Ключевые слова: осморегулирующая функция, недержание, экскреция натрия, десмопрес-
син, диклофенак. 
Introduction
Urine incontinence seems to include several pathogenic forms, as efficient therapy 
is provided by different medications. Commonly used in the treatment of female patients 
with overactive bladder and nocturia is desmopressin which normalizes the water ex-
cretion of the kidney, which is disturbed by a presumed inverted rhythm of vasopressin 
secretion in these patients [1]. Some drugs which eliminate disturbance of urinary blad-
der function are often used. The kidney may also be involved in the therapeutic effect of 
diclofenac which blocks prostaglandin synthase, as vasopressin and prostaglandins are 
known to act competitively in the regulation of renal water reabsorption [2]. The current 
analysis was undertaken to evaluate the clinical efficiency of desmopressine and diclof-
enac in incontinent patients with nocturia.
Materials and methods
277 patients ≥18 ≥ 48 years of age with complaints of urinary incontinence were ana-
lysed according to a specific protocol: urodynamic testing, transperineal ureterovesical 
segment ultrasonography, a 3-day frequency-volume (FV) chart. Nocturia was defined 
as two or more micturitions per night calculated from the FV chart. Night was defined 
as the period of sleep. All participants also performed 24h-urine collection to determine 
the voided volumes and the levels of creatinine, osmolality, sodium, magnesium and po-
tassium for each sample. All urine samples collected for 24 h were divided into two 12-h 
portions: night portion (23:00–07:00) and day portion (07:00–23:00). A blood sample 
was taken during the 24-urine collection to determine the levels of osmolality (using a 
MT-4 osmometer based on determination of freezing point depression, Burevestnik, Rus-
sia), creatinine, sodium, magnesium and potassium (using a Abbott Architect 8000). The 
examination of patients with nocturia was performed twice: in the initial state and 4 weeks 
after the start of treatment with desmopressin or diclofenac. Patients were randomized to 
receive either desmopressin or diclofenac in a double — blind fashion. Optimal dose was 
established through an open-label dose-titration using 0.1 mg, 0.2 mg and 0.4 mg of des-
mopressin (Minirin) or diclofenac using 25 mg, 50 mg and 75 mg twice a day for one week 
each. Patients received their optimal dose for 4 weeks. Safety parameters assessed included 
incidence of adverse events, vital signs and serum sodium levels. The differences in all 
parameters were treated statistically using Student s t-test.
Results
According to a specific protocol 143 women had stress incontinence, 43 — urge 
incontinence and 91  — mixed incontinence. The overall  prevalence  of  nocturia  was 
34.7 ± 2.9% (96  women): 24.5 ± 3.6% in stress incontinence, 46.5 ± 7.6% in urge in-
continence (p<0.01)  and 45.1 ± 5.2% in mixed incontinence (p < 0.01). The nocturics 
were classified into one of the responsible pathophysiologic categories [3]: nocturnal 
polyuria in 30 ± 4.4 % (33  women), a low functional bladder capacity in 12.5 ± 3.4 % 
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(12 women), a combination of both in 28.1 ± 4.6 % (27 women), polyuria was diagnosed 
in 25.0 ± 4.4  % (24 women) of the cases. The frequency of polyuria (24-urine volume 
of 40  mL/kg bodyweight or above) was 7 ± 2.1 % in stress incontinence , 11.6 ± 4.9 % 
in urge incontinence and 9.9 ± 3.1 % in mixed incontinence (p>0.05). The frequency 
of nocturnal polyuria (nocturnal volume / 24-h urine volume of 0.20 or above ) was 
17.5 ± 3.2 % in stress incontinence, 27.9 ± 6.8 % in urge incontinence and 25.3 ± 4.6 % 
mixed incontinence (p > 0.05). 
Lack of significant differences between the studied parameters in patients with 
nocturnal polyuria and polyuria and various types of urine incontinence has allowed to 
unite all samples of patients with polyuria (n = 24) and nocturnal polyuria (n = 60) for 
the further analysis. We have found previously that in patients with polyuria and noc-
turnal polyuria the glomerular filtration rate was normal, whereas diuresis and solute 
(sodium, magnesium, potassium) excretion in night samples in nocturnal polyuria and 
both in night and day samples in polyuria were increased [4]. The higher diuresis and 
the higher solute excretion observed in nocturnal polyuria and polyuria are accompa-
nied by an increase of free water reabsorption. In nocturnal polyuria and polyuria a 
high correlation was found between the free water reabsorption and solute excretion 
(table 1). This occurs against the background of the high night and day osmotic concen-
tration [4]. This study showed that the higher diuresis is accompanied by a reduction of 
ion reabsorption, firstly sodium and magnesium; as a result a higher excretion of solutes 
and water is observed. 
Relation between diuresis, free water reabsorption and osmolal clearance; free water reabsorption, 
diuresis and solute excretion in incontinent women with nocturnal polyuria and polyuria
Parameters
Nocturnal polyuria Polyuria
7.00–23.00 23.00–7.00 7.00–23.00 23.00–7.00
r p r p r p r p
V-Cosm 0.74 0.01 0.81 0.01 0.68 0.01 0.72 0.01
TCH2O-Cosm 0.68 0.01 0.77 0.01 0.76 0.01 0.85 0.01
TCH2O-UNaV 0.73 0.001 0.77 0.001 0.69 0.001 0.64 0.001
TCH2O-UMgV 0.65 0.001 0.54 0.01 0.72 0.001 0.68 0.001
V-UNaV 0.77 0.001 0.55 0.01 0.71 0.001 0.79 0.001
V-UMgV 0.74 0.001 0.68 0.001 0.57 0.01 0.47 0.05
The statistically significant recovery of renal function occurred in 8  incontinent 
women with polyuria and 19  with nocturnal polyuria who received diclofenac and in 
12 incontinent women with polyuria and 18 with nocturnal polyuria who received des-
mopressin (Minirin). In these patients there was a statistically significant decrease in di-
uresis, osmolar clearance and excretion of sodium, potassium and magnesium. Hence, the 
recovery of renal function was similar after treatment with desmopressin and diclofenac 
(picture 1–12).
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Picture 1. Effect of desmopressin on diuresis in polyuria
Picture 2. Effect of desmopressin on osmolal clearance in polyuria
Picture 1–3: *** p < 0.001, ** p < 0.01 — compared with the same parameter 
in control group; ●●● p < 0.001, ●● p < 0.01 — compared with the same parameter 
in polyuria group.
Picture 3. Effect of desmopressin on free water reabsorption in polyuria
Picture 1–3: *** p < 0.001, ** p < 0.01 — compared with the same parameter 
in control group; ●●● p < 0.001, ●● p < 0.01 — compared with the same parameter 
in polyuria group.
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Picture 4. Effect of desmopressin on diuresis in nocturnal polyuria
Picture 5. Effect of desmopressin on osmolal clearance in nocturnal polyuria
Picture 6. Effect of desmopressin on free water reabsorption in 
nocturnal polyuria
Picture 1–6: *** p < 0.001 — compared with the same parameter in control group; 
●●● p < 0.001 — compared with the same parameter in nocturnal polyuria group.
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Picture 7. Effect of diclofenac on osmolal clearance in polyuria
Picture 8. Effect of diclofenac on free water reabsorption in polyuria
Picture 9. Effect of diclofenac on diuresis in polyuria
Picture 1–3: *** p<0.001, ** p<0.01  — compared with the same parameter in 
control group; ●●● p<0.001, ●● p<0.01- compared with the same parameter in poly-
uria group
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Picture 10. Effect of diclofenac on diuresis in nocturnal polyuria
Picture 11. Effect of diclofenac on osmolal clearance in nocturnal polyuria
Picture 11–12: *** p < 0.001 — compared with the same parameter in control group; 
●●● p < 0.001 — compared with the same parameter in nocturnal polyuria group
Picture 12. Effect of diclofenac on free water reabsorption in 
nocturnal polyuria
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Discussion
We have found that nocturia is a common symptom in incontinent women 
(34.7 ± 2.9 %). Nocturia is more often in urge incontinence (p < 0.01) and mixed incon-
tinence (p < 0.01)  than in stress incontinence. The frequency of nocturnal polyuria and 
polyuria as nocturia factors is the same in stress, urge and mixed incontinence. We have 
found previously that in studied patients the cause of polyuria and nocturnal polyuria is a 
higher dieresis due to an elevated solute excretion (sodium, magnesium, potassium) [4]. 
In the current study we were interested in answering the following questions: in which 
part of nephron does the solute transport change with nocturnal polyuria and polyuria, 
which regulatory systems are responsible for the ion excretion, could these data be used 
for pathogenesis — based therapies?
Comparison of the rise in the sodium and magnesium ion excretion allows the lo-
calization of the disturbance of the renal function in the studied forms of nocturnal poly-
uria and polyuria. The thick ascending limb is known to reabsorb up to one-quarter the 
filtered sodium and about a half the filtered magnesium, while in subsequent parts of 
the distal tubule and in collecting ducts there is reabsorption of sodium ions but almost 
no magnesium ions are reabsorbed [5]. These results suggest there is a reduction of ion 
reabsorption in the thick ascending limb of the Henle loop in incontinent women with 
nocturnal polyuria and polyuria. Due to this defect, reabsorption of ions and water is de-
creased; as a result, lager volumes of fluid enter the collecting ducts.
As both desmopressin and prostaglandin E 2 affect the same cell of the thick ascend-
ing limb of Henle’s loop, it is likely that nocturnal polyuria and polyuria result from a dis-
turbed regulation of the function of these cells. Normalization can be achieved either by 
desmopressin administration to stimulate V 2 receptors, wich increase water permeability 
and water reabsorption in collecting ducts as well as ion reabsorption by cells of the thick 
ascending limb of Henle’s loop, or by decrease in prostaglandin production via declofenac 
administration.
These results together with those of desmopressin and diclofenac efficiency in incon-
tinent patients with nocturnal polyuria and polyuria suggest that the increase in diuresis 
and solute excretion might be due either to reduction of the effect of vasopressin on cells 
of the thick ascending limb of Henle’s loop or to an increase in production of prostaglan-
dins or both.
Diclofenac seems to be efficient in patients whose nocturnal polyuria or polyuria due 
to extra production of prostaglandinins which reduce the vasopressin effect. In a propor-
tion of patients the defect is not associated with changed prostaglandin production, in 
these case only desmopressin is an effective treatment.
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